Cannabiz editor-at-large Rhys Cohen says improving patient access needs more than clinics and trail-blazing doctors.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

It’s been nearly six years since I first got involved in medicinal cannabis policy in Australia. Recently I’ve been trying to take a longer-term view of things, looking back at some of the challenges we’ve experienced and the progress that we’ve made as a community.

I remember the first time we saw the number of monthly SAS-B approvals hit 100, back in 2018. It was a brutal time for patient access, but hitting 100 felt like a real achievement. The next year we broke 1,000. Two years after that we hit 10,000.

Rhys Cohen

As well as being editor-at-large at Cannabiz, Rhys is the director of Cannabis Consulting Australia, which provides commercial consulting services to various domestic and international cannabis companies....